Computed Tomography Evaluation of Small Bowel Ischemia
Executive Summary
Mesenteric ischemia (MI) remains a critical surgical emergency characterized by insufficient blood supply to the bowel. Despite advancements in medical technology, it carries a staggering mortality rate of 50–90%. The condition is a "deadly puzzle" due to its nonspecific clinical presentation, requiring a high index of suspicion for timely intervention.
Acute Mesenteric Ischemia (AMI) accounts for 95% of cases and is categorized into four etiological forms: arterial embolism, arterial thrombosis, venous thrombosis, and nonocclusive ischemia. Multi-Detector Computed Tomography (MDCT) and CT Angiography (CTA) have emerged as the primary diagnostic tools, offering 89–100% sensitivity. Successful outcomes are tethered to strict clinical timelines: a provisional diagnosis should be reached within 30 minutes, a formal diagnosis within 2 hours, and surgical intervention within 4 hours of presentation.
Clinical Urgency and Timeframe Goals
The prognosis for mesenteric ischemia is heavily dependent on the speed of diagnosis and treatment. Failure to recognize AMI leads to mesenteric infarction, intestinal necrosis, and death. The following clinical benchmarks are recommended for optimal management:
Provisional Diagnosis: Should be established within <30 minutes of patient presentation.
Formal Diagnosis: Must be confirmed within <2 hours of presentation.
Surgical Intervention: Should be performed within <4 hours of diagnosis.
Interventional Radiology: In select cases, IR procedures should be available within <90 minutes.
Etiological Classification of Mesenteric Ischemia
Mesenteric ischemia is broadly classified into Acute Mesenteric Ischemia (AMI) and Chronic Mesenteric Ischemia (CMI). AMI is further divided based on the underlying cause of vascular compromise.
Acute Mesenteric Ischemia (AMI) - 95% of Cases
Chronic Mesenteric Ischemia (CMI) - 5% of Cases
CMI is predominantly caused by atherosclerotic stenosis (90% of cases) affecting at least two of the three major mesenteric vessels (celiac artery, SMA, IMA). Symptoms include:
Postprandial pain: Pain occurring after eating.
Sitophobia: Fear of eating due to subsequent pain.
Weight loss: Often severe due to reduced caloric intake.
Computed Tomography (CT) Imaging Protocols
MDCT is the first-line imaging modality because it is noninvasive and allows for rapid assessment of vascular patency and bowel wall integrity.
Optimized CT Protocol for Suspected AMI
Multiphase Imaging: Essential phases include unenhanced (optional), arterial (30 seconds post-contrast), and portovenous (60 seconds post-contrast).
Intravenous Contrast: 120 mL of iodinated contrast (350 mg/mL) administered at a high flow rate (5 mL/s).
Oral Contrast: Generally not recommended. Positive contrast (barium/iodine) masks bowel wall enhancement and mesenteric vessels. Neutral contrast (water) may be used but often delays diagnosis and poses an aspiration risk.
Reconstruction: Axial, coronal, and sagittal reformats are necessary. 3D maximum intensity projection (MIP) helps visualize vascular anatomy.
Key Radiological Imaging Features
Diagnostic confidence relies on a spectrum of CT findings involving the vasculature, the bowel wall, and the mesentery.
1. Vascular Findings
Filling Defects: Central hypodense defects in the SMA suggest EAMI. Eccentric defects near the SMA ostium on a background of atherosclerosis suggest TAMI.
Vessel Caliber: In arterial ischemia, SMA caliber may be greater than SMV. In VAMI, the SMV is often engorged and larger than the SMA.
Vasospasm: Associated with NOMI, where mesenteric vessels remain patent but narrowed.
2. Bowel Wall Characteristics
Thickness: Normal wall thickness is 3–5 mm.
Thinning ("Paper-thin"): Classic sign of arterial occlusion (EAMI/TAMI) due to lack of inflow.
Thickening (6 mm–1.5 cm): Most common in VAMI or NOMI due to mural edema and hemorrhage.
Attenuation: Increased attenuation on non-contrast CT indicates submucosal hemorrhage (highly specific). Decreased attenuation indicates edema.
Enhancement Patterns:
Hypoenhancement: Suggests active ischemia.
Target Sign: A stratified pattern of inner mucosal hyperdensity, middle submucosal hypodensity (edema), and outer serosal hyperdensity. This indicates hyperemia and typically suggests bowel viability or reperfusion.
3. Mesentery and Secondary Signs
Fat Stranding and Ascites: Common in VAMI due to venous engorgement. In arterial ischemia, these are late signs indicating advanced disease or infarction.
Bowel Dilation: Fluid pooling in aperistaltic segments; often associated with transmural ischemia.
Pneumatosis Intestinalis (PI) and Portomesenteric Gas: The presence of air within the bowel wall or venous system is nearly 100% specific for bowel ischemia in the presence of other abnormal findings. It usually represents late-stage transmural infarction.
Conclusion
The diagnosis of mesenteric ischemia is a time-critical challenge. Clinical symptoms are often vague, particularly in elderly or critically ill populations. MDCT/CTA serves as the diagnostic cornerstone, but radiologists and surgeons must interpret findings—such as the "target sign" or "paper-thin" walls—within the specific etiological context (arterial vs. venous vs. nonocclusive). Adherence to the under-four-hour surgical window remains the most vital factor in reducing the high mortality associated with this condition.